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Abstract
Background: Inter-racial differences in disease characteristics and in the management of Crohn’s disease (CD) have been
described in African American and Asian subjects, however for the racial groups in South Africa, no such recent literature
exists.
Methods: A cross sectional study of all consecutive CD patients seen at 2 large inflammatory bowel disease (IBD) referral
centers in the Western Cape, South Africa between September 2011 and January 2013 was performed. Numerous
demographic and clinical variables at diagnosis and date of study enrolment were identified using an investigator
administered questionnaire as well as clinical examination and patient case notes. Using predefined definitions, disease
behavior was stratified as ‘complicated’ or ‘uncomplicated’.
Results: One hundred and ninety four CD subjects were identified; 35 (18%) were white, 152 (78%) were Cape Coloured and
7(4%) were black. On multiple logistic regression analysis Cape Coloureds were significantly more likely to develop
‘complicated’ CD (60% vs. 9%, p = 0.023) during the disease course when compared to white subjects. In addition,
significantly more white subjects had successfully discontinued cigarette smoking at study enrolment (31% vs. 7%
reduction, p = 0.02). No additional inter-racial differences were found. A low proportion of IBD family history was observed
among the non-white subjects.
Conclusions: Cape Coloured patients were significantly more likely to develop ‘complicated’ CD over time when compared
to whites.
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Introduction
A subtype of inflammatory bowel disease (IBD), Crohn’s disease
(CD) is believed to result from a complex interplay between
genetic susceptibility and one or more environmental triggers. The
disease is characterized as a chronic immune-mediated disorder of
the gastrointestinal tract which may or may not be accompanied
by a variety of extraintestinal or systemic complications. Disease
presentation and severity are known to vary between individuals,
having important implications for disease management [1,2].
Thus, in recent years, issues of CD sub-classification by phenotype
have been reviewed, and the Montreal classification system [2]
(revised Vienna) is the accepted standard.
Crohn’s disease is found in all racial groups worldwide.
However, historically, the highest prevalence rates have been
reported in white populations, particularly those of North America
and Europe, with significantly lower rates seen in black and Asian
populations within these or any other foreign country [3–12]. As
such, the majority of reports contributing to our understanding of
disease presentation and clinical course originate primarily from
Western populations, leaving a paucity of literature regarding the
racial variability of CD phenotype [5,12–14].
Earlier epidemiological observations have suggested that CD
presents in a more severe form in African American and Asian
populations compared to their white counterparts [15–17], yet
findings have been inconsistent, often limited by small sample size
and variations in disease classification methods. Recently however,
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reports indicate that the incidence of IBD in both African
American and Asian populations has been steadily rising over the
decades [18–22]. This increase in incidence may be attributed to
one of several factors namely, changes in utilization and
accessibility of hospital care (suggesting an underreporting of
previous incidence rates), selection bias of IBD centers, or a true
rise in the incidence among these racial groups [23]. Therefore,
aspects surrounding the racial variations in CD phenotype should
continue to be explored and include all non-white populations in
order to further contribute towards our understanding of the
environmental and genetic factors involved in the disease etiology.
The aim of our study was thus to provide a preliminary and
descriptive view on disease phenotype of the racial groups in Cape
Town, South Africa.
Materials and Methods
The study protocol and questionnaire were reviewed and
approved by the Senate Research Ethics Committee of the
University of the Western Cape (Reg no. 11/3/16), the Human
Research Ethics Committee of the University of Cape Town
(HREC REF: 122/2011) and the Provincial Department of
Health. All participants gave written informed consent. http://dx.
doi.org/10.6084/m9.figshare.1041586.
Design and Setting
This was a cross sectional examination (part of a larger case-
control study) of all consecutive white, Cape Coloured and black
CD patients seen at Groote Schuur Hospital (GSH) and
Tygerberg Hospital (TBH) during normally scheduled appoint-
ments between September 2011 and January 2013. GSH and
TBH manage all public-sector IBD patients within the Western
Cape, South Africa. Of the 3.5 million persons who reside in the
greater Cape Town area, approximately 90% rely on the public-
sector health services [24]. Cape Coloureds are subjects of mixed-
ancestry. The term which is non-derogatory refers to a heteroge-
neous ethnic group of which genome analysis has now identified
South Asian, European, Indonesian and isiXhosa sub-Saharan
blacks as the four predominant genetic contributors [25]. Disease
diagnosis was defined by the European Crohn’s and Colitis
Organization (ECCO) guidelines [26].
Following informed consent, data relating to patient demo-
graphics, smoking and disease symptoms prior to diagnosis were
collected via an interviewer administered questionnaire. Race was
self-reported. Information relating to disease characteristics and
disease course were determined via review of patient medical
records as well as clinical examination by the consulting
gastroenterologist. Monthly income was determined using com-
puterized hospital records. Only patients with complete data at
diagnosis were included. Patients were excluded if disease duration
was less than 5 years, or had a prior diagnosis of intestinal
tuberculosis. In accordance with the paper published by Epstein et
al. [27] there is no gold standard in the differential diagnosis
between CD and intestinal tuberculosis however as per the
algorithm suggested by these authors every attempt was made to
exclude a diagnosis of tuberculosis.
The Montreal classification system [2] (Table 1) was used to
define age of onset, disease location and disease behavior at two
time intervals; initial diagnosis and date of study enrolment. Any
disease related surgical history was categorized by timing of first
surgery in relation to initial diagnosis. Information on medical
management included lifetime use of immunomodulator, anti-
tumor necrosis factor inhibitors or 5-aminosalicylates. Complicat-
ed disease was defined as the presence of any one of the following
at diagnosis or during subsequent follow ups: stricturing CD,
penetrating CD, perianal fistulas or surgical resection. Data on
extraintestinal manifestations (EIMs) was divided into four
categories: (1) skin, (2) ocular, (3) joint and (4) other. Skin
manifestations included erythema nodosum, pyoderma gang-
renosum, and neutrophilic dermatoses. Ocular manifestations
included uveitis, iritis, and episcleritis. Joint manifestations
included arthralgias, arthritis and axial arthropathies. The ‘other’
manifestations included ankylosing spondylitis and primary biliary
cirrhosis.
Data Analysis
Descriptive data is presented overall as well as separately for the
three racial groups (white, Cape Coloured and black) as medians
(IQRs) for numerical data, and as frequencies and percentages for
categorical data. The Kruskall-Wallis test was used to compare
racial groups with respect to their medians for the numeric
demographic variables and the Fisher’s exact test was used to
compare the percentages for the categorical variables. All
statistical analysis included only white and Cape Coloured
subjects, due to the small number of black subjects. A separate
multiple logistic regression model was conducted for each
phenotype (age of onset, disease location and disease behavior)
to test for an association between the phenotype and racial groups
(whites and Cape Coloureds), adjusting for possible confounders
age of onset, gender, smoking and duration of symptom onset as
appropriate. Separate contingency tables for medication use,
surgical interventions and EIMs versus racial group were
conducted and the Fisher’s exact test was used to test for
associations. No adjustments were made in the latter analysis. A
generalized linear model (GEE with an unstructured correlation
matrix) was used to test for an interaction between racial groups
and smoking and phonotype from diagnosis to study enrolment.
The standard for significance for all analysis was P,0.05.
Results
Demographic Characteristics of Subjects
Over an approximate seventeen month period, 194 CD patients
meeting our inclusion criteria were identified and consented to the
study, 35 (18%) were white, 152 (78%) were Cape Coloured and 7
(4%) were black. Two patients that were approached declined to
participate (response rate = 99%). Demographic and baseline
characteristics for each racial group are shown in Table 2.
Overall, 9 (26%) white, 41 (27%) Cape Coloured and 3 (43%)
black subjects were male. The median age at enrolment was 47.0
(IQR 38–57) years, the median age of disease onset was 28 (IQR
21.5–38.0) years and median disease duration was 16 (IQR 10.0–
24.0) years. The majority of subjects in all racial groups were born
in South Africa (95%), but individually, 100% of the Cape
Coloureds compared to 77% of the white subjects, were born in
South Africa (p,0.001). There was no significant difference in the
level of education between the white and Cape Coloured subjects,
however there was a significant difference in the median age at
study enrolment [52.0 (IQR 40.0–67.5) years vs. 46.0 (IQR 38.0–
55.5) years, respectively] as whites were on average six years older
at study enrolment (p = 0.04). Comparing white subjects with their
Cape Coloured counterparts, median disease duration [22.0 (IQR
10.5–25.0) years vs. 16.0 (IQR 10.0–24.0) years] and median
duration of initial presenting symptoms [2.0 (IQR 0.6–3.5) years
vs. 1.0 (IQR 0.5–3.0) years], appeared longer in the white subjects,
although results did not reach statistical significance. No significant
inter-racial difference was found in the smoking habits for white
and Cape Coloured subjects at diagnosis (74% vs. 63%). When
The Association between Race with Crohn’s Disease in South Africa
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comparing the change in smoking habits from time of diagnosis to
study enrolment for the racial groups, we found a significant
interaction (Chi-Square = 5.4; p = 0.02), and the results indicated
that the reduction of 31% smoking for whites was significant
(p = 0.001), but the reduction of 6.8% Cape Coloureds smoking
was not significant (p = 0.08).
Disease Characteristics between Racial Groups
On multiple logistic regression analysis there was no significant
difference between Cape Coloured and white subjects with regards
to disease location or disease behavior at diagnosis (p.0.05;
Table 3). However after a median disease duration of 16 years,
significantly more Cape Coloured subjects had developed ‘com-
plicated’ CD (60% vs. 9%, p = 0.023) during the disease course
Table 1. Montreal Classification Scheme.





L1 Isolated to the terminal ileum
L2 Isolated to the colon
L3 Ileum and colonic involvement
L4* Upper gastrointestinal tract
Disease behavior
B1{ Inflammatory; non-stricturing, non-penetrating
B2 Stricturing
B3 Penetrating disease, with or without stricturing, excludes perianal penetrating disease
p` Perianal disease modifier
*Upper gastrointestinal (GI) modifier (L4) can be added to L1–L3 when concomitant upper GI disease present.
{B1 category should be considered ‘‘interim’’ until a pre-specified time has elapsed from time of diagnosis. Suggested time period is between 5–10 years.
`‘‘p’’ is added to B1–B3 when concomitant perianal disease is present.
doi:10.1371/journal.pone.0104859.t001
Table 2. Demographic and Baseline Characteristics of Patients.
White (n = 35) Cape Coloured (n = 152) Black (n = 7) Overall (N = 194) p-value*
Gender, no. (%) Males 9 (26) 41 (27) 3 (43) 53 (27) 0.88
Females 26 (74) 111 (73) 4 (57) 141 (73)
Age at enrolment (median and IQR), yr.{ 52.0 (40.0, 67.5) 46.0 (38.0, 55.5) 44.0 (38.0, 46.0) 47 (38.0, 57.0) 0.04
Age at diagnosis (median and IQR), yr. 28.0 (21.5, 45.5) 28.5 (21.5, 45.5) 29.0 (26.5, 33.5) 28 (21.5, 38.0) 0.24
Disease duration (median and IQR), yr. 22.0 (10.5, 25.0) 16.0 (10.0, 24.0) 12.0 (9.5, 14.0) 16 (10.0, 24.0) 0.30
Duration presenting symptoms (median and IQR), yr. 2.0 (0.6, 3.5) 1.0 (0.5, 3.0) 1.0 (0.2, 1.0) 1.0 (0.5, 3.5) 0.58
Married, no. (%)` 14 (40) 78 (51) 1 (14) 93 (48) 0.64
Education, no. (%)1 13 (37) 21 (14) 2 (29) 36 (18) 0.12
Born in South Africa, no. (%) 27 (77) 152 (100) 5 (71) 184 (95) ,0.001
Income per month, no. (%)
,R3000 30 (86) 127 (84) 6 (86) 163 (84) 0.74
R3000–10,000 4 (11) 23 (15) 1 (14) 28 (14)
.R10,000 1 (3) 2 (1) 0 (0) 3 (1)
Smoking history, no. (%)a At diagnosis 26 (74) 95 (63) 6 (86) 127 (65) 0.42
At study enrolment 15 (43) 87 (57) 2 (29) 104 (54) 0.09
Family History IBD, no. (%)b 5 (14) 10 (6) 0 (0) 15 (7) 0.75
IQR, interquartile range; IBD, inflammatory bowel disease.
*Statistical analysis excluding black subjects. No subjects reported being of Indian or Asian ethnicity.
{Age at study enrolment missing for 1 Cape Coloured subject.
`Civil marriage or living with a partner.
1At least some tertiary education.
aSmoking status at diagnosis; data missing for 5 subjects. Smoking status at study enrolment; data missing for 7 subjects.
bFamily history IBD defined as parents, siblings or offspring.
doi:10.1371/journal.pone.0104859.t002
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when compared to whites (results not shown). There was however
no significant inter-racial difference in terms of EIMs, surgical or
medical management over disease course (Table 4).
Although the numbers were too small for meaningful analysis all
black subjects developed complicated CD within a mean of 1.71
(SD61.25) years after initial diagnosis. In addition 43% already
had a penetrating disease phenotype or perianal fistulas at
diagnosis. None of the black subjects reported a first degree
family history of IBD, compared to 6% of the Cape Coloured and
14% of the white patients. Overall, less than 10% of patients had a
family history of IBD.
Discussion
Population based epidemiological studies remain of paramount
importance in piecing together the complex pathogenesis under-
lying CD, particularly in terms of inter-racial variations of disease
phenotype. In South Africa, while a number of earlier reports are
available, no such recent data exists for the population; a
population broadly classified into three ethnic groups: black south
African, white and Cape Coloured.
This study included all consecutive state-sector adult CD
patients within the Western Cape, South Africa seen over a
seventeen month period. Comparing Cape Coloured subjects with
their white counterparts, a significant difference in the develop-
ment of ‘complicated’ CD (60% vs. 9%) over time was noted. One
possible explanation is the high prevalence of ongoing active
smoking in Cape Coloureds at study enrolment. Cigarette smoking
is a well described risk factor for the development of complicated
and aggressive CD over time [28]. The rate of complicated CD in
our white subjects was lower compared to that described in other
populations. It is possible that the discrepancy in disease course
can be attributed to differences in treatment strategies, patient
compliance to medical management, or true microbial differences
between populations, but these factors were not investigated. In
addition, recent reports indicate that prevalence of systemic lupus
erythematosus, particularly among the black and Coloured
females in Cape Town, South Africa is higher than previously
thought [29,30]. However in this present study, no concomitant
diagnosis of CD and systemic lupus erythematosus was found,
suggesting that different factors contribute to the etiology of the
two diseases.
In keeping with reports from Asia [31–44], among our Cape
Coloured subjects, ileo-colonic appeared to be the most common
location at diagnosis. Interestingly in contrast to white patients,
Cape Coloured subjects appeared to have a shorter duration of
presenting symptoms in years until diagnosis. These findings are at
odds with the widely held belief that the disease is frequently
overlooked in this population due to the high rates of tuberculosis
and infectious diarrhea, or poor access to health care. Notably, the
public-sector health care system in South Africa predominantly
caters to those who are of lower socioeconomic standing. In this
study, findings are likely not attributed to inter-racial differences in
access to healthcare or medical treatment as there was no
significant inter-racial difference in the level of income. Moreover
education is considered to be a good marker of socioeconomic
status and in our cohort, there was no significant inter-racial
difference in the level of education.
Family history of IBD is considered one of the strongest
predisposing risk factors in CD. However in our cohort 6% of the
Cape Coloured and none of the black patients reported having a
first degree family member with IBD. In contrast 14% of the white
subjects had a positive family history, the latter compatible with
Western data (10–25%) [43,45,46]. This finding may reflect racial
differences in CD susceptibility mutations. A study of South
African Coloureds failed to demonstrate an association with 3
nucleotide oligomerization domain (NOD-2) mutations commonly
seen in the West [47]. Moreover, significant differences of allele
and genotype frequencies in the -237CRT promoter polymor-
phisms of the SCL11A1 gene, a gene implicated in CD
susceptibility [48], were observed in South African Coloured CD
patients, but not in their white and black counterparts [49].
Similar discrepancies have been observed in Japanese [50,51],
Han Chinese [52–54], Korean [55], Indian [56] and Malaysian
[57] populations [58,59].
A five year retrospective study [60] based on the GSH
gastrointestinal clinic patient lists, found an increasing CD




(n = 152) Black (n = 7) Overall (n = 194) p-value*
Medication use over disease course, no. (%){ Corticosteroids 6 (17) 32 (21) 1 (14) 39 (20) 0.82
5-aminosalicylates 10 (29) 60 (40) 0 (0) 70 (36) 0.32
Immunomodulators 19 (54) 109 (72) 4 (57) 132 (68) 0.48
Tumor necrosis factor inhibitors 1 (3) 8 (5) 0 (0) 9 (5) 1.00
Lifetime surgical intervention, no. (%) 14 (40) 86 (57) 4 (57) 104 (54) 0.16
Timing of first surgery after diagnosis, no. (%)` Within 1 year 6 (17) 44 (29) 2 (29) 52 (27) 0.84
Within 1–5 years 2 (6) 17 (11) 1 (14) 20 (10)
After 5 years 4 (11) 21 (14) 1 (14) 26 (13)
Type of EIM over disease course, no. (%) Skin 3 (9) 13 (9) 2 (29) 18 (93) 1.00
Ocular 0 (0) 2 (1) 1 (14) 3 (2) 1.00
Joint 10 (29) 46 (30) 3 (43) 59 (30) 0.37
Other1 1 (3) 2 (1) 0 (0) 3 (2) 0.46
*Statistical analysis excludes black patients.
{Excludes 15 patients with insufficient records of medical management.
`Excludes 12 patients with incomplete records of surgical dates.
1Other EIM disorders included; ankylosing spondylitis and primary biliary cirrhosis.
doi:10.1371/journal.pone.0104859.t004
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incidence in the Coloured population; from 0.4/100 000 per year
during 1970–1974 [61] to 1.3/100 000 per year during 1975–
1980. Of the 117 CD patients reviewed; 32 were Coloured and
only 1 was black. In contrast, we found 152 Cape Coloured and 7
black, consecutive CD state sector patients. Given the significant
socioeconomic, dietary and lifestyle changes that have taken place
over the past two decades, it is likely that our findings indicate an
epidemiological transition among these racial groups, a trend
noted in developed and developing countries alike [5,18]. These
observed trends in our Cape Coloured and black subjects lend
support to both different susceptibility genes and variable
environmental interactions between racial groups, implying
distinctions in disease pathogenesis or risk.
Our study was limited by the small number of black subjects. It
is possible that over a longer period, including patients from both,
the state and private sector, a larger sample size would be drawn.
Data regarding medication use has been poorly captured in the
past, as this was a retrospective study, details on the type medical
treatment used, duration of treatment, dosage and adherence was
difficult to determine, and may have contributed to the identified
inter-racial differences. Similarly, given the retrospective nature of
the study, the exact parameters used to exclude tuberculosis
diagnosis (i.e., histological, radiological, endoscopic), were not
available to report in this paper. Our cohort may have included a
higher proportion of patients with ‘complicated’ disease as GSH
and TBH are both referral based IBD centers. Poor socioeco-
nomic status is associated with helminth infection and in South
Africa helminth infection has been shown to be protective against
IBD development [62]. Therefore it is entirely possible that within
our cohort this may have influenced the severity of CD between
the racial groups however this was not one of the variables
evaluated in the present study. The ethnic diversity of our cohort
was also not representative to that of the Western Cape, as 2011
provincial estimates approximate (N = 5,822,734) 15.7% of the
population as white, 48.8% as Colored and 32.9% as black
(excluding Indian and Asian ethnicities) [63]. We also did not
verify the self-reported race using genetic markers. However,
validity of self-reported racial status has been previously acknowl-
edged, as very low rates of discordance between self-reported
racial status and genetic markers have been described [25,64,65].
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